Dr. Jennifer A. Maynard's lab at the University of Texas at Austin focuses on developing new treatments for aggressive breast cancer, particularly for patients who do not respond to current therapies. Her research aims to create advanced antibody-drug conjugates (ADCs) that target specific protein variants associated with poor patient outcomes. By engineering antibodies to work selectively in the tumor microenvironment, her lab seeks to improve treatment effectiveness while minimizing side effects.

Dr. Elena Maria Zannoni's lab at the University of Texas at Austin focuses on creating innovative robot-assisted imaging technologies to enhance medical diagnostics. The primary project involves developing a reconfigurable SPECT imaging system that adapts to individual patient needs, aiming for increased accuracy, reduced scan times, and lower radiation exposure. This cutting-edge research combines robotics, imaging technology, and advanced algorithms to improve patient care.